ArticleMarine drugs2019
Desertomycin G, a New Antibiotic with Activity against Mycobacterium tuberculosis and Human Breast Tumor Cell Lines Produced by Streptomyces althioticus MSM3, Isolated from the Cantabrian Sea Intertidal Macroalgae Ulva sp.
Abstract read
In one paragraph
Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Microbial Natural Products Targeting theMicroorganisms · 2026Review
- Marine Bacteria as a Source of Antibiotics AgainstMarine drugs · 2026Review
- NRPS and PKS pathways in actinomycetes: A review of biosynthetic diversity and bioactive potential.Current research in pharmacology and drug discovery · 2026Review
- Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks.Natural products and bioprospecting · 2025Review
- Inhibitory Activity of Compounds Obtained fromPathogens (Basel, Switzerland) · 2025Article
- Diversity of secondary metabolites from marine Streptomyces with potential anti-tubercular activity: a review.Archives of microbiology · 2025Review
- Article
- Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review.Frontiers in microbiology · 2025Review
- Actinomycetota From Macroalgae as Rich Source for Natural Products Discovery Revealed Through Culture-Dependent and -Independent Approaches.Microbial biotechnology · 2024Article
- Discovery of anti-Mycobacterium tuberculosis desertomycins from Streptomyces flavofungini TRM90047 based on genome mining and HSQC-TOCSY.Scientific reports · 2024Article
- Biotechnological potential of actinomycetes in the 21st century: a brief review.Antonie van Leeuwenhoek · 2024Review
- Bioprospecting of unexplored halophilic actinobacteria against human infectious pathogens.3 Biotech · 2023Review
- Streptomyces polyketides mediate bacteria-fungi interactions across soil environments.Nature microbiology · 2023Article
- Natural Products and Biological Activity from Actinomycetes Associated with Marine Algae.Molecules (Basel, Switzerland) · 2023Review
- Secondary Metabolites from Marine-Derived Bacteria with Antibiotic and Antibiofilm Activities against Drug-Resistant Pathogens.Marine drugs · 2023Review
- Marine Macrolides to Tackle Antimicrobial Resistance ofMarine drugs · 2022Review
- Marine Actinobacteria a New Source of Antibacterial Metabolites to Treat Acne Vulgaris Disease-A Systematic Literature Review.Antibiotics (Basel, Switzerland) · 2022Review
- Exploring the Diversity and Antibacterial Potentiality of Cultivable Actinobacteria from the Soil of the Saxaul Forest in Southern Gobi Desert in Mongolia.Microorganisms · 2022Article
- Cytotoxic compounds from marine actinomycetes: Sources, Structures and Bioactivity.Acta materia medica · 2022Article
- Natural Products from Actinomycetes Associated with Marine Organisms.Marine drugs · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Alfredo F BrañaDepartamento de Biología Funcional, Área de Microbiología, e Instituto Universitario de Oncología del Principado de Asturias. Universidad de Oviedo, 33006 Oviedo, Spain. afb@uniovi.es.ORCID 0000-0002-3277-9085
Aida Sarmiento-VizcaínoDepartamento de Biología Funcional, Área de Microbiología, e Instituto Universitario de Oncología del Principado de Asturias. Universidad de Oviedo, 33006 Oviedo, Spain. UO209983@uniovi.es.
Ignacio Pérez-VictoriaFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores Andalucía, Avda. del Conocimiento 34, Parque Tecnológico de Ciencias de la Salud, E-18016, Granada, Spain. ignacio.perez-victoria@medinaandalucia.es.ORCID 0000-0002-4556-688X
Jesús MartínFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores Andalucía, Avda. del Conocimiento 34, Parque Tecnológico de Ciencias de la Salud, E-18016, Granada, Spain. jesus.martin@medinaandalucia.es.
Luis OteroServicio de Microbiología. Hospital de Cabueñes, 33203 Gijón, Spain. oteroluis@uniovi.es.ORCID 0000-0002-5026-0164
Juan José Palacios-GutiérrezServicio de Microbiología. Hospital Universitario Central de Asturias, 33011 Oviedo, Spain. juanjose.palacios@sespa.es.
Jonathan FernándezServicio de Microbiología. Hospital Universitario Central de Asturias, 33011 Oviedo, Spain. jofersua@hotmail.com.
Yamina MohamediDepartamento de Bioquímica y Biología Molecular, e Instituto Universitario de Oncología del Principado de Asturias. Universidad de Oviedo, 33006 Oviedo, Spain. yamomu@hotmail.com.
Tania FontanilDepartamento de Bioquímica y Biología Molecular, e Instituto Universitario de Oncología del Principado de Asturias. Universidad de Oviedo, 33006 Oviedo, Spain. taniuskina@gmail.com.
Marina SalmónDepartamento de Biología Funcional, Área de Microbiología, e Instituto Universitario de Oncología del Principado de Asturias. Universidad de Oviedo, 33006 Oviedo, Spain. marinasalmon92@gmail.com.
Santiago CalDepartamento de Bioquímica y Biología Molecular, e Instituto Universitario de Oncología del Principado de Asturias. Universidad de Oviedo, 33006 Oviedo, Spain. santical@uniovi.es.
Fernando ReyesFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores Andalucía, Avda. del Conocimiento 34, Parque Tecnológico de Ciencias de la Salud, E-18016, Granada, Spain. fernando.reyes@medinaandalucia.es.ORCID 0000-0003-1607-5106
Luis A GarcíaDepartamento de Ingeniería Química y Tecnología del Medio Ambiente. Área de Ingeniería Química, Universidad de Oviedo, 33006 Oviedo, Spain. luisag@uniovi.es.ORCID 0000-0003-3233-3582
Gloria BlancoDepartamento de Biología Funcional, Área de Microbiología, e Instituto Universitario de Oncología del Principado de Asturias. Universidad de Oviedo, 33006 Oviedo, Spain. gbb@uniovi.es.
Funding
FILTERABLE AGENTS AND TUMOR INDUCTION IN MICER01CA010000 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI POGO, BEATRIZ G. · 1985 to 1987
–Gobierno del Principado de Asturias SV-PA-13-ECOEMP-62Ministerio de Ciencia e Innovación INP-2011-0016-PCT-010000 ACT6Ministerio de Ciencia e Innovación PCT-010000-2010-4Universidad de Oviedo UNOV-11-MA-02
Abstract
The isolation and structural elucidation of a structurally new desertomycin, designated as desertomycin G (
Indexed as
Antibiotics, AntineoplasticAntitubercular AgentsBiological ProductsCell Line, TumorDrug Screening Assays, AntitumorFemaleGram-Negative BacteriaGram-Positive BacteriaHumansMacrolidesMicroalgaeMicrobial Sensitivity TestsMycobacterium tuberculosisStreptomycesAntibiotics, AntineoplasticAntitubercular AgentsBiological ProductsdesertomycinMacrolidesactinomycetesdesertomycinintertidal seaweedmacrolideseaweed associated actinobacteriaStreptomyces
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.